|
1
|
Dreinhofer KE, Mitchell PJ, Bégué T,
Cooper C, Costa ML, Falaschi P, Hertz K, Marsh D, Maggi S, Nana A,
et al: A global call to action to improve the care of people with
fragility fractures. Injury. 49:1393–1397. 2018.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Horowitz JA, Puvanesarajah V, Jain A, Raad
M, Gjolaj JP, Shen FH and Hassanzadeh H: Fragility fracture risk in
elderly patients with cervical myelopathy. Spine (Phila Pa 1976).
44:96–102. 2019.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Friedman SM and Mendelson DA: Epidemiology
of fragility fractures. Clin Geriatr Med. 30:175–181.
2014.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Wasserman H, Backeljauw PF, Khoury JC,
Kalkwarf HJ and Gordon CM: Bone fragility in Turner syndrome:
Fracture prevalence and risk factors determined by a national
patient survey. Clin Endocrinol (Oxf). 89:46–55. 2018.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Oryan A, Monazzah S and Bigham-Sadegh A:
Bone injury and fracture healing biology. Biomed Environ Sci.
28:57–71. 2015.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Cheng C and Shoback D: Mechanisms
underlying normal fracture healing and risk factors for delayed
healing. Curr Osteoporos Rep. 17:36–47. 2019.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Mohr AM and Mott JL: Overview of microRNA
biology. Semin Liver Dis. 35:3–11. 2015.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Wang CZ, Deng F, Li H, Wang DD, Zhang W,
Ding L and Tang JH: MiR-101: A potential therapeutic target of
cancers. Am J Transl Res. 10:3310–3321. 2018.PubMed/NCBI
|
|
9
|
Zhang B, Yi J, Zhang CL, Zhang QH, Xu JF,
Shen HQ and Ge DW: MiR-146a inhibits proliferation and induces
apoptosis in murine osteoblastic MC3T3-E1 by regulating Bcl2. Eur
Rev Med Pharmacol Sci. 21:3754–3762. 2017.PubMed/NCBI
|
|
10
|
Li X, Li K, Yu G, Yu C and Liu C:
miR-342-5p inhibits expression of Bmp7 to regulate proliferation,
differentiation and migration of osteoblasts. Mol Immunol.
114:251–259. 2019.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Tu XM, Gu YL and Ren GQ: miR-125a-3p
targetedly regulates GIT1 expression to inhibit osteoblastic
proliferation and differentiation. Exp Ther Med. 12:4099–4106.
2016.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Hu WX, Li H and Jiang JZ: MiR-491-3p is
down-regulated in postmenopausal osteoporosis and affects growth,
differentiation and apoptosis of hFOB1.19 cells through targeting
CTSS. Folia Histochem Cytobiol. 1:9–16. 2020.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Pan S, Ren F, Li L, Liu D, Li Y, Wang A,
Li W, Dong Y and Guo W: MiR-328-3p inhibits cell proliferation and
metastasis in colorectal cancer by targeting Girdin and inhibiting
the PI3K/Akt signaling pathway. Exp Cell Res.
390(111939)2020.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Yi W, Tu MJ, Liu Z, Zhang C, Batra N, Yu
AX and Yu AM: Bioengineered miR-328-3p modulates GLUT1-mediated
glucose uptake and metabolism to exert synergistic
antiproliferative effects with chemotherapeutics. Acta Pharm Sin B.
10:159–170. 2020.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Weilner S, Skalicky S, Salzer B, Keider V,
Wagner M, Hildner F, Gabriel C, Dovjak P, Pietschmann P,
Grillari-Voglauer R, et al: Differentially circulating miRNAs after
recent osteoporotic fractures can influence osteogenic
differentiation. Bone. 79:43–51. 2015.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Malaney P, Uversky VN and Dave V: PTEN
proteoforms in biology and disease. Cell Mol Life Sci.
74:2783–2794. 2017.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Li D, Li L, Chen X, Gao Y, Cao Y and Hao
B: LncRNA GHET1 promotes osteoblast proliferation and
differentiation by inhibiting PTEN. Panminerva Med Jul 29, 2019
(Online ahead of print).
|
|
19
|
Xu W, Yang Z, Xie C, Zhu Y, Shu X, Zhang
Z, Li N, Chai N, Zhang S, Wu K, et al: PTEN lipid phosphatase
inactivation links the hippo and PI3K/Akt pathways to induce
gastric tumorigenesis. J Exp Clin Cancer Res.
37(198)2018.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Einhorn TA and Gerstenfeld LC: Fracture
healing: Mechanisms and interventions. Nat Rev Rheumatol. 11:45–54.
2015.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Zhao C, Zhou Y, Ran Q, Yao Y, Zhang H, Ju
J, Yang T, Zhang W, Yu X and He S: MicroRNA-381-3p functions as a
dual suppressor of apoptosis and necroptosis and promotes
proliferation of renal cancer cells. Front Cell Dev Biol.
8(290)2020.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Lang Y, Sun Q, Zhu LM, Qiu XD, Hu BS, Yang
J and Zhang JD: MiR-25 overexpression promotes fracture healing by
activating the Wnt signaling pathway. Eur Rev Med Pharmacol Sci.
23:7200–7208. 2019.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Mi B, Xiong Y, Chen L, Yan C, Endo Y, Liu
Y, Liu J, Hu L, Hu Y, Sun Y, et al: CircRNA AFF4 promotes
osteoblast cells proliferation and inhibits apoptosis via the
Mir-7223-5p/PIK3R1 axis. Aging (Albany NY). 11:11988–12001.
2019.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Zhang SY, Gao F, Peng CG, Zheng CJ and Wu
MF: Hsa-miR-203 inhibits fracture healing via targeting PBOV1. Eur
Rev Med Pharmacol Sci. 22:5797–5803. 2018.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Shi J, An G, Guan Y, Wei T, Peng Z, Liang
M and Wang Y: miR-328-3p mediates the anti-tumor effect in
osteosarcoma via directly targeting MMP-16. Cancer Cell Int.
19(104)2019.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Li JZ, Li J and Liu BZ: MicroRNA-328-3p
inhibits malignant progression of hepatocellular carcinoma by
regulating MMP-9 level. Eur Rev Med Pharmacol Sci. 23:9331–9340.
2019.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Rommens PM, Wagner D and Hofmann A:
Fragility fractures of the pelvis. JBJS Rev.
5:01874474–201703000-00004. 2017.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Rossi LMM, Copes RM, Dal Osto LC, Flores
C, Comim FV and Premaor MO: Factors related with osteoporosis
treatment in postmenopausal women. Medicine (Baltimore).
97(e11524)2018.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Chen R, Liao X, Chen F, Wang B, Huang J,
Jian G, Huang Z, Yin G, Liu H and Jin D: Circulating microRNAs,
miR-10b-5p, miR-328-3p, miR-100 and let-7, are associated with
osteoblast differentiation in osteoporosis. Int J Clin Exp Pathol.
11:1383–1390. 2018.PubMed/NCBI
|
|
30
|
Zhou Y, Wang M, Zhang J, Xu P and Wang H:
MicroRNA-29a-3p regulates abdominal aortic aneurysm development and
progression via direct interaction with PTEN. J Cell Physiol.
235:9414–9423. 2020.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Zha X, Xi X, Fan X, Ma M, Zhang Y and Yang
Y: Overexpression of METTL3 attenuates high-glucose induced RPE
cell pyroptosis by regulating miR-25-3p/PTEN/Akt signaling cascade
through DGCR8. Aging (Albany NY). 12:8137–8150. 2020.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Ge JB, Lin JT, Hong HY, Sun YJ, Li Y and
Zhang CM: MiR-374b promotes osteogenic differentiation of MSCs by
degrading PTEN and promoting fracture healing. Eur Rev Med
Pharmacol Sci. 22:3303–3310. 2018.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Burgers TA, Hoffmann MF, Collins CJ,
Zahatnansky J, Alvarado MA, Morris MR, Sietsema DL, Mason JJ, Jones
CB, Ploeg HL and Williams BO: Mice lacking pten in osteoblasts have
improved intramembranous and late endochondral fracture healing.
PLoS One. 8(e63857)2013.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Liu Y, Liu J, Xia T, Mi BB, Xiong Y, Hu
LC, Ruan TY, Zhou W and Liu GH: MiR-21 promotes fracture healing by
activating the PI3K/Akt signaling pathway. Eur Rev Med Pharmacol
Sci. 23:2727–2733. 2019.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Sun Z, Liu F, Cai X, Yu W, Xu L and Yang
B: MiR-126 affects femoral fracture healing in rats through
PI3K/AKT signaling pathway. Panminerva Med Jun 28, 2019.
|
|
36
|
Yao LZ, Zhu YL and Liu JJ: Inhibition of
PTEN gene expression by small interfering RNA on PI3K/Akt/FoxO3a
signaling pathway in human nasopharyngeal carcinoma. Technol Cancer
Res Treat 19: 1533033820917959, 2020.
|
